These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19934274)

  • 1. Celastrol synergistically enhances temozolomide cytotoxicity in melanoma cells.
    Chen M; Rose AE; Doudican N; Osman I; Orlow SJ
    Mol Cancer Res; 2009 Dec; 7(12):1946-53. PubMed ID: 19934274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug.
    Caporali S; Levati L; Graziani G; Muzi A; Atzori MG; Bonmassar E; Palmieri G; Ascierto PA; D'Atri S
    J Transl Med; 2012 Dec; 10():252. PubMed ID: 23259744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.
    Li ZY; Li QZ; Chen L; Chen BD; Wang B; Zhang XJ; Li WP
    Neurochem Res; 2016 Dec; 41(12):3192-3205. PubMed ID: 27632183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propolis changes the anticancer activity of temozolomide in U87MG human glioblastoma cell line.
    Markiewicz-Żukowska R; Borawska MH; Fiedorowicz A; Naliwajko SK; Sawicka D; Car H
    BMC Complement Altern Med; 2013 Feb; 13():50. PubMed ID: 23445763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulforaphane reverses chemo-resistance to temozolomide in glioblastoma cells by NF-κB-dependent pathway downregulating MGMT expression.
    Lan F; Yang Y; Han J; Wu Q; Yu H; Yue X
    Int J Oncol; 2016 Feb; 48(2):559-68. PubMed ID: 26648123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation.
    Sethi G; Ahn KS; Pandey MK; Aggarwal BB
    Blood; 2007 Apr; 109(7):2727-35. PubMed ID: 17110449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of c-Jun N-terminal kinase enhances temozolomide-induced cytotoxicity in human glioma cells.
    Ohba S; Hirose Y; Kawase T; Sano H
    J Neurooncol; 2009 Dec; 95(3):307-316. PubMed ID: 19517066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner.
    Wagner L; Marschall V; Karl S; Cristofanon S; Zobel K; Deshayes K; Vucic D; Debatin KM; Fulda S
    Oncogene; 2013 Feb; 32(8):988-97. PubMed ID: 22469979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death.
    Kashyap T; Argueta C; Aboukameel A; Unger TJ; Klebanov B; Mohammad RM; Muqbil I; Azmi AS; Drolen C; Senapedis W; Lee M; Kauffman M; Shacham S; Landesman Y
    Oncotarget; 2016 Nov; 7(48):78883-78895. PubMed ID: 27713151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.
    Sai K; Li WY; Chen YS; Wang J; Guan S; Yang QY; Guo CC; Mou YG; Li WP; Chen ZP
    Am J Chin Med; 2014; 42(2):485-503. PubMed ID: 24707876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-α sensitizes breast cancer cells to natural products with proteasome-inhibitory activity leading to apoptosis.
    Lu L; Shi W; Deshmukh RR; Long J; Cheng X; Ji W; Zeng G; Chen X; Zhang Y; Dou QP
    PLoS One; 2014; 9(11):e113783. PubMed ID: 25419573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73.
    Thangasamy T; Sittadjody S; Mitchell GC; Mendoza EE; Radhakrishnan VM; Limesand KH; Burd R
    BMC Cancer; 2010 Jun; 10():282. PubMed ID: 20540768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound.
    Caporali S; Alvino E; Starace G; Ciomei M; Brasca MG; Levati L; Garbin A; Castiglia D; Covaciu C; Bonmassar E; D'Atri S
    Pharmacol Res; 2010 May; 61(5):437-48. PubMed ID: 20026273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifolate activity of pyrimethamine enhances temozolomide-induced cytotoxicity in melanoma cells.
    Chen M; Osman I; Orlow SJ
    Mol Cancer Res; 2009 May; 7(5):703-12. PubMed ID: 19435820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-κB.
    Levati L; Ruffini F; Muzi A; Umezawa K; Graziani G; D'Atri S; Lacal PM
    Int J Oncol; 2011 Jan; 38(1):241-7. PubMed ID: 21109946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
    Roussel RR; Barchowsky A
    Arch Biochem Biophys; 2000 May; 377(1):204-12. PubMed ID: 10775461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-κB-dependent pathway.
    Huang H; Lin H; Zhang X; Li J
    Oncol Rep; 2012 Jun; 27(6):2050-6. PubMed ID: 22426504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy.
    Yang J; Zaja-Milatovic S; Thu YM; Lee F; Smykla R; Richmond A
    Mol Cancer Ther; 2009 Mar; 8(3):636-47. PubMed ID: 19276165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celastrol inhibits lipopolysaccharide-induced angiogenesis by suppressing TLR4-triggered nuclear factor-kappa B activation.
    Ni H; Zhao W; Kong X; Li H; Ouyang J
    Acta Haematol; 2014; 131(2):102-11. PubMed ID: 24157922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.